The support team can walk you through plan changes, dose adjustments, or pausing treatment
MWN-101 is an Fc-fusion protein in Phase 2 since March 2024 - notably, MWN-101's Fc architecture suggests a longer half-life than a standard fatty-acid-conjugated peptide, which would support less-frequent-than-weekly dosing
Most patients need it most during dose-escalation (first 36 months)
MDLive $99-$299 Omada Health Omada Health is one of the most established digital health companies in the United States, founded in 2011 years before GLP-1 medications became a cultural phenomenon
The app works with any GLP-1, wherever it is prescribed
PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after your first treatment month), which analyzes how your unique genetics influence peptide pathway activation and medication response